Bristol-Myers Squibb
BMY
2,300 hedge funds and large institutions have $76.1B invested in Bristol-Myers Squibb in 2025 Q2 according to their latest regulatory filings, with 149 funds opening new positions, 826 increasing their positions, 1,035 reducing their positions, and 308 closing their positions.
9% more capital inflows, than outflows
Capital inflows: $6.6B | Capital outflows: $6.08B
0.53% more ownership
Funds ownership: 80.26% → 80.79% (+0.53%)
8% less funds holding
Funds holding: 2,487 → 2,300 (-187)
12% less call options, than puts
Call options by funds: $1.12B | Put options by funds: $1.26B
20% less repeat investments, than reductions
Existing positions increased: 826 | Existing positions reduced: 1,035
52% less first-time investments, than exits
New positions opened: 149 | Existing positions closed: 308
57% less funds holding in top 10
Funds holding in top 10: 37 → 16 (-21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$533M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$500M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$479M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$450M |
| 5 |
Man Group
London,
United Kingdom
|
+$270M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$553M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$442M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$383M |
| 4 |
Bank of New York Mellon
New York
|
-$295M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$265M |
BMY Hedge Fund Activity: Q2 2025 in Review
2,300 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2025, worth a combined $76.1B — down 24% from $100B a quarter earlier.
Sellers outnumbered buyers: 308 funds closed out of BMY and 149 opened new positions — a net loss of 159 holders — while 1,035 trimmed existing stakes and 826 added.
The largest buyer was BlackRock, adding an estimated $533M. The largest seller was DZ Bank, cutting an estimated $553M.
- 2,300 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2025, down from 2,487 in Q1 2025.
- Funds reported $76.1B of Bristol-Myers Squibb stock for Q2 2025, down 24% quarter-over-quarter.
- 149 funds opened new Bristol-Myers Squibb positions in Q2 2025 and 308 closed out, a net change of -159 holders.
- The largest Bristol-Myers Squibb buyer in Q2 2025 was BlackRock, an estimated $533M added.
- The largest Bristol-Myers Squibb seller in Q2 2025 was DZ Bank, an estimated $553M sold.
Based on aggregated 13F filings for Q2 2025.